Get started

Bullishpattern

SKIPPER Price Action## SKIPPER Price Analysis (August 2025) ### Price & Market Metrics - Latest share price is approximately ₹538.75. - Market capitalization stands around ₹6,074–6,085crore. - The 52-week low is ₹341.55 (April 2025) and the high is ₹665.00 (December 2024). - Recent price trend: Strong rebound from April lows, with current price near the top of the recent trading range. - Day range on August 13: ₹505.10 – ₹538.20. ### Returns & Volatility - 1-month gain: About 12%. - 1-year return: Roughly 33–35%, outperforming broader indices and sector averages. - 3-year return: Over 880%. - Skipper often sees daily volatility in the 2–6% range, especially during August. Historically, Augusts show flat average returns but are characterized by abrupt price changes both upward and downward. ### Financial Performance - Trailing 12-month EPS: ₹14.37. - TTM net profit: About ₹158.9crore. - Net sales for the last reported quarter (June 2025): ₹1,253.86crore, up 14.85% YoY. - Consolidated net sales (March 2025): ₹1,287.75crore, up 11.64% YoY. - Profit margin is moderate—company has low interest coverage and return on equity relative to valuation. ### Valuation - P/E ratio: 35–37, well above sector average. - P/B ratio: About 5.1. - Dividend yield is very low, with most earnings retained. - Book value per share: ₹105.69. ### Qualitative & Technical Notes - The company’s growth is supported by solid export and infrastructure orders, but margins and returns remain modest compared to peers. - Promoter holding is robust (around two-thirds of shares). - Technical trend is positive, with outperformance versus sector and key moving averages, but sharp swings are common and corrections have occurred previously after strong rallies. - Stock currently trades above estimated fair value and sector multiples. *** ### Summary SKIPPER has rebounded powerfully from earlier lows and is now trading near multi-month highs, supported by strong sales growth and consistent profitability. However, the valuation has become elevated with respect to sector and intrinsic value metrics, while dividend yield remains nominal. Daily volatility and historical instability in August should be considered alongside strong long-term returns and positive business momentum—investors should be alert to potential price corrections or swings at these levels.
NSE:SKIPPERLong
by KamalKJoshi
SPMLINFRA Price ActionSPML Infra Ltd (SPMLINFRA) is exhibiting notable momentum and price appreciation in 2025: - **Current Price**: Around ₹289–₹308 as of August 2025. - **Performance**: - 1-year return is strong at about 45.5%, with a **21% increase in the past month** and **3.6% in the past week**. - Recent volatility: The price has fluctuated from lows around ₹136 up to a high of ₹323 in the last year. - **Valuation**: - **P/E Ratio**: Approximately 42, indicating aggressive pricing compared to earnings. - **P/B (Price to Book)**: Around 2.6, reflecting the market’s willingness to pay a premium over the company’s asset value. - **Market Cap**: About ₹2,038 crore. - **Profitability**: - **ROE** (Return on Equity): ~8% for the last year, but 3.7% over the past three years, which is modest. - **EBITDA Margin**: About 5.5%. - **Strong Profit Growth**: 49% CAGR over 5 years; sharp turnaround recently, although past sales growth has been negative. - **Concerns**: - **Sales Growth**: Negative (-15% CAGR over 5 years). - **High Promoter Pledge**: About 27% of promoter shares are pledged, which may be a risk. - High debt and debtor days remain elevated. - **Dividend**: No dividend payout. - **Momentum Rank**: Among the top 21% companies showing bullish momentum currently. **Conclusion**: SPML Infra’s stock price reflects recent bullish momentum, despite muted sales growth and some balance sheet risks. Profit growth and operational improvements have buoyed sentiment, but the high valuation metrics and promoter pledging warrant caution. The stock is considered volatile, and investors should monitor fundamentals alongside price trends.
NSE:SPMLINFRALong
by KamalKJoshi
Radico Price ActionRadico Khaitan’s stock is trading around ₹2,840 as of early August 2025, having climbed sharply from about ₹2,700 in July and near ₹2,050 back in February. The share price hit an all-time high at the start of August and has more than doubled over the past 12 months, outperforming its peers in the spirit and beverages sector. Recent price momentum has been driven by strong financial results: for the quarter ending June 2025, Radico reported net sales of over ₹1,500 crore, a year-on-year increase of more than 32%. Market capitalization is robust and the stock is actively traded, with volumes surging during rally periods. However, valuation is elevated: the price-to-book ratio is around 14 and price-to-earnings is at the high end for its segment, reflecting rich investor expectations. Operationally, Radico maintains steady margins and has shown above-average revenue growth, consistently launching new premium products and expanding distribution. The company’s return on equity averages about 11–12% over three years, slightly below top FMCG performers but stable. Technically, the stock is in a strong uptrend, trading well above major moving averages, but may be considered overbought in the very short term after recent rapid gains. Liquidity remains healthy, supporting continued volatility and trading opportunities. In summary, Radico Khaitan is a high-growth, well-established spirits company with strong recent sales and a share price at historic highs. While fundamentals support continued strength, caution is warranted given expensive valuations and the potential for short-term corrections following such a swift rally.
NSE:RADICOLong
by KamalKJoshi
Gopal Snacks Ltd Price ActionGopal Snacks Ltd’s share price is around ₹359.5 as of August 3, 2025. Over the past year, the stock has shown only a modest increase (up about 1%), with greater strength seen in the last six months (up 7%). The 52-week range is broad, with a high near ₹520 and a low around ₹253, indicating significant volatility. Average daily trade volumes have also risen, supporting liquidity. The company’s financial performance for FY25 shows total revenue at approximately ₹1,474 crore, a slight rise over FY24. However, net profit slumped sharply to ₹19 crore in FY25 from ₹100 crore a year earlier, with the operating profit margin declining to about 5.3% (from nearly 10%). EPS stands at ₹1.52 for the most recent year. Key ratios—P/E around 82.7 and P/B near 11—point to a premium valuation, especially considering the weak recent profit growth. Operationally, Gopal Snacks has faced challenges, including a significant quarterly loss attributed to rising costs and a one-off fire incident, which hurt margins and caused a 12% revenue drop that quarter. As a result, compounded profit growth is negative for the trailing twelve months, and return on equity dropped to 14% (from nearly 27% over the previous three years). Promoter holding remains high (over 81%), but the stock is classified as high-risk, with volatility more than three times that of the broader Nifty index. Despite a positive dividend payout ratio (now around 66%), overall yield remains modest at less than 0.3%. In summary, Gopal Snacks Ltd is a small-cap FMCG stock trading markedly below its 52-week highs, reflecting weak earnings momentum after a challenging year. Stronger long-term fundamentals and established market presence support the stock, but recent headwinds—including falling margins, higher volatility, and rich valuations—call for investor caution if seeking near-term upside.
NSE:GOPAL
by KamalKJoshi
PDMJEPAPER Price ActionPudumjee Paper Products (PDMJEPAPER) trades near ₹125 as of early August 2025, with 52-week highs around ₹232 and lows near ₹90. The stock has demonstrated moderate to high volatility in recent months, with sharp daily moves both upward and downward. Over the last three months, the share price has risen roughly 4–5%, though its one-year return is negative, down about 5%. In contrast, the stock remains an exceptional long-term outperformer: up over 200% in 3 years and roughly 720% over 5 years. Short-term price trends show a recovery from late June and July lows near ₹110–116, gaining back strength towards ₹125 by August. The market capitalization stands at approximately ₹1,100 crore, and analyst platforms suggest the current valuation is around 11–12 times earnings, with a price-to-book below 2, implying moderate valuation relative to recent growth. Turnover and liquidity are healthy, with notable volume spikes during price rallies. The company has also outperformed its sector over multi-year periods. Historically, returns in August are mixed, but positive August rallies have been observed in recent years. Operationally, Pudumjee Paper remains a mid-cap paper manufacturer with a focus on volume growth and steady, positive operating margins. While dividend yields are modest, financial stability is reflected in recent results. Investors should remain cautious due to past volatility and the cyclical nature of the paper sector, but the stock’s long-term performance signals strong sector positioning and improving fundamentals. This summary is based on current market prices and trends as of August 2025, with emphasis on key performance and valuation metrics, and does not include references to specific data sources.
NSE:PDMJEPAPERLong
by KamalKJoshi
Suzlon Energy Price ActionSuzlon Energy’s share price is around ₹66 as of early August 2025. The stock price has shown strong volatility with a 52-week high near ₹86 and a low around ₹46. Over the last three months, the price has gained about 17%, but it has declined slightly by around 2–3% over the past year. Long-term gains are impressive, with the stock appreciating over 850% in 3 years and over 1,400% in 5 years. Financially, Suzlon posted robust revenue growth of approximately 67% year-on-year, with revenues crossing ₹10,800 crore in the latest fiscal year. Profitability has surged, highlighted by a net profit increase of over 200%, strong EBITDA margins near 16–18%, and return on equity above 40%. The company has a healthy order book of 5.6 GW, indicating strong future revenue visibility. Valuation metrics show a high price-to-earnings ratio around 40-43 and a price-to-book ratio near 14, reflecting elevated investor expectations. The stock carries a high beta near 2.6, indicating it is more volatile than the overall market. Suzlon’s debt has been reduced significantly over recent years, improving financial stability. The firm is a leading player in India's wind energy sector, supported by government policies and large-scale renewable targets. Seasonally, August tends to be a weaker month historically, but recent positive news like major turbine order wins have boosted sentiment. While the stock shows high growth potential and strong operational execution, its elevated valuation and volatility call for caution among short-term investors. Overall, Suzlon Energy stands as a high-beta, high-growth renewable energy company with solid financial turnaround. This analysis describes recent market and financial data without specific source references, focusing on key trends and metrics as of August 2025.
NSE:SUZLONLong
by KamalKJoshi
Gold Took Support – Now Bulls Are in Control! Gold Took Support – Now Bulls Are in Control! Gold (XAUUSD) price has taken a strong bounce from the support zone, and now it’s looking bullish. Market reacted nicely from the demand zone, which means buyers are stepping in again. 📊 Technical Analysis: ✅ Strong Support Zone (3260–3280): This area is acting like a strong base. Price touched here and immediately bounced — showing buying pressure. 🔄 Break of Structure (BOS): Market broke the previous structure and gave signs of trend reversal. It also grabbed liquidity from the lows. 🟩 Bullish Fair Value Gap (FVG): A clean FVG was formed and respected, which shows institutional activity and buying interest. 🎯 Target Level – 3366.984 USD: If bullish momentum continues, gold can easily move towards this level. It’s also near a previous resistance. 📚 Educational Points: Market took liquidity from the lows and reversed Fair Value Gap is respected, adding confirmation Structure break confirms buyers are in control Price is heading towards the next resistance zone 📌 Conclusion: Gold is now in a bullish phase. As long as the support zone is holding, buyers can stay confident. Target remains near 3366–3380 USD. Any pullback can give a good buy opportunity.
OANDA:XAUUSDLong
by Mentor_Michael03
1
CCL Price Action CCL Products (India) Ltd is currently trading around ₹852 to ₹890 as of early August 2025, with a market capitalization near ₹11,370–₹12,000 crore. The stock has shown strong recent momentum, rising about 37% over six months and around 50% in the past three months, reflecting robust investor confidence. The company reported consolidated quarterly revenues of approximately ₹835 crore and profits around ₹100 crore, with annual figures showing about ₹3,100 crore in total income and ₹310 crore in net profit, indicating solid operational performance and growth. Valuation metrics show a price-to-earnings (P/E) ratio near 37 and price-to-book (P/B) ratio above 6, which reflect a premium valuation consistent with the company's growth trajectory and market position in the agri and agri inputs sector. CCL Products pays a modest dividend with a yield below 1%, while costs related to employee expenses and interest are well managed relative to revenues. Technical signals recently indicate bullish trends, suggesting potential short-term upside, though the stock price remains near its recent highs. In summary, CCL Products (India) Ltd is exhibiting strong price appreciation backed by solid revenue and profit growth. Its premium valuation highlights investor expectations for continued growth, but potential buyers should consider the high multiples and the cyclicality of the agri inputs sector when assessing near-term risk and reward.
NSE:CCLLong
by KamalKJoshi
PGHL Price ActionProcter & Gamble Health Ltd (PGHL) is currently trading around ₹5,900 as of early August 2025. The stock has shown decent upward momentum, with a price range around ₹5,700 to ₹6,000 in recent weeks, though it has experienced some volatility within this band. PGHL has delivered solid returns over the past year, roughly 15%, and longer-term growth is also positive with a multi-year compounded annual growth rate in the double digits. The company maintains a market capitalization close to ₹9,850 crore and offers a dividend yield around 4.4%, providing steady income to shareholders. Valuation metrics indicate PGHL trades at a premium, justified by its stable revenue growth and presence in the health and pharmaceutical segment. While short-term price fluctuations occur, the overall outlook remains favorable, supported by consistent operational performance and dividend payouts. In summary, PGHL is a fundamentally sound health sector stock with solid past returns, moderate volatility, and reasonable dividend income, suitable for investors looking for stable growth in the healthcare industry.
NSE:PGHLLong
by KamalKJoshi
Narayana Hrudayalaya Ltd Price ActionNarayana Hrudayalaya Ltd (NH) is trading around ₹1,946 as of August 1, 2025, after hitting a record high of ₹2,370 in late June. The stock has gained over 53% in the past year and about 44% in the last six months, showing strong long-term momentum, though it has corrected nearly 10% over the previous month and 2% in the past week. Financially, NH remains robust. For the trailing twelve months, revenue stands at approximately ₹5,483 crore and net profit at ₹791 crore, giving a net profit margin of about 14.4%. The company’s market capitalization is close to ₹39,900 crore, making it one of the largest listed hospital operators in India. Key financial ratios include a price-to-earnings (P/E) ratio of about 49.5 and a price-to-book (P/B) ratio nearing 18—both substantially above the sector average, reflecting strong premium and optimistic growth expectations. Operating performance continues to impress: sales growth for the March quarter was up 15% year-on-year, while margins are stable and efficient. The most recent dividend declared is ₹4.50 per share, maintaining a rising payout trend. Technically, momentum is slightly negative in the short term, with bearish signals on daily moving averages and a recent drop below key short-term exponential averages, suggesting the possibility of near-term consolidation or mild pullback after a strong prior rally. In summary, NH remains a growth leader in the hospital and healthcare space, combining strong recent price performance and operational strength. The stock is trading at a substantial premium, justified by consistent growth and sector leadership, but near-term upside may be limited as the price consolidates from recent highs and digest valuation multiples, especially if no further earnings acceleration materializes.
NSE:NHLong
by KamalKJoshi
Hester Price ActionAs of July 31, 2025, Hester Biosciences Ltd is trading near ₹1,950 after a recent rebound, though it has experienced a significant decline over the past year, down roughly 37% from its 52-week high above ₹3,250. The stock’s recovery in the last three months has been moderate, with gains of about 9%, and short-term sentiment appears slightly positive given the recent upward movement. The company’s current price-to-earnings ratio is elevated, close to 58, and the price-to-book ratio is about 4.9, indicating a premium valuation compared to its book value. Hester Biosciences maintains a market capitalization near ₹1,650 crore, placing it among smaller specialty pharma and agri-biotech firms. While the core fundamentals show resilience, the firm recently reported a contraction in sales for the first time in three years, which led to some investor caution. Technically, Hester Biosciences is recovering from its yearly lows near ₹1,240 and is showing renewed buying interest at current levels, confirmed by an uptick in volumes and momentum. However, given the sharply reduced returns over the past year, sentiment is mixed, and further upside will likely depend on improvement in financial result trends and any breakout above resistance points established during its downtrend. Overall, the near-term outlook is cautiously constructive with recent stabilization, but investors should monitor for sustained improvements in revenue and earnings to confirm a continued reversal.
NSE:HESTERBIOLong
by KamalKJoshi
RHIM Price ActionRHI Magnesita India Ltd (RHIM) is trading around ₹529 in early August 2025, having shown notable volatility over the past several months. The stock has ranged between a recent low of about ₹503 and a high near ₹538 in the last few days. The annual performance indicates a mild decline over the last year but double-digit gains in the last three to six months, pointing to a marked recovery from earlier lows. Financially, RHIM carries a relatively high valuation, with a price-to-earnings ratio close to 54 and a price-to-book value of about 2.8. Operating fundamentals are decent but not exceptional: return on equity remains moderate, and promoter holdings have slightly decreased over the past few years. The company offers a modest dividend yield of about 0.5%, providing limited income support to investors. In terms of recent momentum, trading volumes have spiked, indicating renewed interest, and short-term technicals suggest the possibility of continued oscillation within the current price band. The stock’s long-term prospects remain tied to trends in the refractories and industrial materials sector, where growth has been consistent but not rapid. In summary, RHIM is exhibiting renewed price momentum but continues to trade at elevated valuation multiples. The company’s stable position in its sector and improving sentiment support the stock at current levels, though further substantial upside will likely depend on sustained earnings growth and sector expansion.
NSE:RHIMLong
by KamalKJoshi
Kajaria Ceramics Price ActionKajaria Ceramics is currently trading around ₹1,177, with a market capitalization close to ₹18,750 crore as of the end of July 2025. The stock has shown solid performance in recent months—up about 46% over the last quarter and nearly 19% in the past six months, although it experienced a mild 0.2% dip over the last week. Despite this rally, the stock is valued at a relatively high price-to-earnings (P/E) ratio of around 59 and a price-to-book (P/B) ratio of approximately 6.6, suggesting that it is trading at a premium to its asset base and compared to industry averages. Profit growth has lagged sales growth, with annual sales increasing modestly but profit growth remaining subdued. The 52-week price range is quite wide, with a high of ₹1,579 and a low of ₹759, reflecting periods of both volatility and strong recoveries. Analyst outlook remains moderately positive, with one-year price targets averaging near ₹1,259 but estimates ranging widely from ₹731 to ₹1,716. Near-term forecasts mostly see the price consolidating between ₹1,150–₹1,200, with oscillations rather than sustained moves upward or downward. In summary, Kajaria Ceramics stands out for its recent price momentum and market strength. However, its stretched valuation multiples and only moderate earnings growth highlight the need for careful consideration if expecting further near-term appreciation. The company's premium valuation is reliant on continued improvement in industry demand and profitability. Its financial position and recent run-up make it a stable but potentially fully valued pick at present levels.
NSE:KAJARIACERLong
by KamalKJoshi
TIINDIA Price ActionTata Investment Corporation Ltd (TIINDIA) is mainly an investment holding company, and its share price reflects both its portfolio performance and market sentiment. At present, the company maintains a very strong financial position with almost no debt, providing security for shareholders. Its stock is trading at a valuation close to its book value, suggesting a fair price relative to its underlying assets. However, the actual returns from TIINDIA’s own operations remain modest. Return on equity is low and profit growth has been muted in recent years, which indicates limited profitability from its core business. The company’s strong dividend history provides stable income to investors, but earnings growth remains subdued. Despite a substantial rise in the stock price over the past several years, more recent performance has slowed, aligning with weaker earnings growth. The high price-to-earnings ratio, when compared to its limited profit generation, implies that the stock may be fully valued or even expensive at current levels. Future upside for TIINDIA is likely to depend heavily on a significant rebound in the market value or profits of its investment portfolio. Overall, TIINDIA offers stability and low financial risk, but prospects for sharp appreciation are currently limited unless there’s a meaningful turnaround in its earnings or portfolio companies.
NSE:TIINDIALong
by KamalKJoshi
5
Zuari Price ActionAs of July 24, 2025, Zuari Agro Chemicals Ltd is trading around ₹215 to ₹218 per share. The stock has shown a recent slight decline of about 1.27% on that day. Its market capitalization is approximately ₹900 crore, placing it among the mid-sized chemical and fertilizer companies. The 52-week price range for Zuari Agro Chemicals is between ₹169 and ₹268, reflecting moderate volatility over the past year. The stock is trading closer to the lower-middle part of this range, about 18–20% below its 52-week high. Fundamentally, the company demonstrates reasonable valuation metrics, with a price-to-earnings (P/E) ratio near 5.5, which is quite attractive compared to the sector average, and a price-to-book (P/B) ratio below 0.5, indicating it is trading at a significant discount to book value. Recent earnings per share show solid growth, contributing to strong profitability metrics. Operationally, Zuari Agro Chemicals continues to build stable revenues within the fertilizers segment, benefitting from sectoral demand and government policies supporting agriculture inputs. The company maintains average financial strength with ongoing measures to reduce debt and improve operational efficiency. On the technical front, the stock has experienced some consolidation after modest gains over recent months but remains vulnerable to market sentiment shifts in the commodity and fertilizer sectors. Overall, Zuari Agro Chemicals offers a fair valuation entry for investors seeking exposure to the fertilizer industry with moderate risk. The current price implies value relative to its historical range, supported by steady earnings, though the stock price is subject to volatility driven by agricultural commodity cycles and sector-specific factors.
NSE:ZUARILong
by KamalKJoshi
1
Infobean – Triangle Consolidation with Volume SpikeAfter a sharp one-sided rally, the price entered a prolonged consolidation phase. Instead of the usual parallel-channel flag formation, the structure has evolved into a descending triangle with slightly lower highs and marginally lower lows. What stands out is the recent significant volume expansion—often called a “volume buster.” While the shape resembles a pole-then-consolidation setup, the breakout structure and volume shift highlight an important phase change in market activity. I have only created how I would Draw it and try to get some information out of it. (This is a structural observation, not a buy/sell recommendation.)
NSE:INFOBEANLong
by Averoy_Apoorv_Analysis
CAPLIPOINT Price ActionAs of July 31, 2025, Caplin Point Laboratories Ltd (CAPLIPOINT) is trading near ₹2,085, showing a mixed but steady performance with some recent price fluctuations around this level. The stock briefly touched intraday highs around ₹2,095 and lows near ₹2,030, maintaining support in the ₹2,030–₹2,055 range. Market capitalization stands broadly near ₹15,590 crore. Caplin Point benefits from solid fundamentals in the pharmaceutical sector, supported by consistent revenue growth and operational efficiencies. The price-to-earnings ratio sits around 29, while the price-to-book ratio is approximately 5.5, indicating premium valuation relative to book but in line with sector expectations. Dividend yield is low at about 0.15%, reflecting the company’s focus on growth over payout. Technically, the stock tends to hover above its medium-term moving averages like the 50-day and 200-day SMAs, showing cautious bullish momentum, although near-term volatility remains. Trading volumes are moderate, and the relative strength index is near mid-range levels, suggesting balanced momentum without overbought or oversold extremes. Overall, Caplin Point Laboratories currently reflects steady fundamentals with a valuation premium typical of its pharma peer group, supported by stable trading ranges and positive medium-term technical signals. The near-term outlook remains cautiously optimistic, with key support near ₹2,030 and potential resistance around ₹2,100–₹2,120.
NSE:CAPLIPOINTLong
by KamalKJoshi
Jubilant Price ActionAs of July 31, 2025, Jubilant Pharmova Ltd is trading around ₹1,236, showing strong bullish momentum with gains of over 7% in recent sessions. The stock has recovered well from lower levels near ₹1,170 seen earlier, with sustained buyer interest and solid volume support. Technical indicators reveal that the price is above its short-term moving averages, reflecting positive market sentiment. Fundamentally, Jubilant Pharmova maintains a robust position in the pharmaceutical and life sciences sector with steady revenue growth and improving profitability. The company benefits from a diversified business model and ongoing operational efficiencies, which have helped it sustain earnings growth amid industry challenges. Valuation metrics like the price-to-earnings ratio are moderate, reflecting reasonable investor confidence relative to sector peers. The near-term outlook for Jubilant Pharmova appears constructive, with potential for further upside provided it holds above key support levels around ₹1,170–₹1,180. Momentum indicators and volume trends support the continuation of the uptrend, although investors should remain cautious of profit-booking risks after sharp rallies. In summary, Jubilant Pharmova demonstrates solid fundamental strength and positive technical signs, making it an appealing choice for investors seeking exposure to the pharmaceutical sector with a growth orientation.
NSE:JUBLPHARMALong
by KamalKJoshi
Refex Price ActionAs of July 31, 2025, Refex Industries is trading near ₹448, showing strong bullish momentum with recent gains of about 10% in the last day. The stock has held well above key support levels near ₹400–₹430, indicating solid buyer interest. It has a market capitalization close to ₹5,800 crore. Fundamentally, Refex Industries carries a price-to-earnings ratio around 33 and a price-to-book ratio above 4, which suggests a premium valuation supported by solid profitability—the return on equity stands near 30%. Technically, the stock trades above short- and medium-term moving averages such as the 5-day, 10-day, and 20-day SMAs, with some resistance expected around ₹450–₹465. Breaking above this level could open further upside potential toward ₹480–₹500. Volume trends in recent sessions confirm the strength of the price move, and the relative strength index (RSI) indicates room for further upside before becoming overbought. In summary, Refex Industries exhibits strong upward price action backed by healthy fundamentals and volume support. Key levels to watch include support near ₹400–₹430 and resistance at ₹450–₹465, with the near-term outlook remaining constructive on sustained momentum.
NSE:REFEXLong
by KamalKJoshi